Keywords: α; apha; ALT; alanine aminotransferase; ANOVA; analysis of variance; AST; aspartate transaminase; β; beta; cART; combination antiretroviral therapy; C; control; DAB; liquid 3âµ3-diaminobenzidine; DPX; distyrene/plasticizer/xylene; EFV; efavirenz; eGFR;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: HIV; human immunodeficiency virus; RT; reverse transcriptase; NNRTI; non-nucleoside reverse transcriptase inhibitor; NRTI; nucleoside reverse transcriptase inhibitor; WT; wild-type; K101P; Lysine101Proline; IC50; inhibition concentration at 50%; EC50; eff
Keywords: 3TC; lamivudine; ABC; abacavir; ACN; acetonitrile; aCSF; artificial cerebrospinal fluid; CNS; central nervous system; CSF; cerebrospinal fluid; ER; extraction recovery; ESI; electrospray ionization; FA; formic acid; FTC; emtricitabine; FWHM; full width at
Keywords: AIDS; acquired immune deficiency syndrome; ALV; avian leukosis virus; AMV; avian myeloblastosis virus; APOBEC; apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like; ASLV; avian sarcoma leukosis virus; AZT; 3â² -azido-3â² -deoxythymidine; BIV;
Keywords: Aβ; amyloid beta; AD; Alzheimer's disease; ADDL; amyloid-β-derived diffusible ligand; ALS; amyotrophic lateral sclerosis; ApoE; apolipoprotein E; ART; antiretroviral therapy; BBB; blood-brain barrier; CNS; central nervous system; CSF; cerebral spina
Keywords: ARV; antiretroviral; ART; antiretroviral treatment; EID; Early Infant Diagnosis of HIV; HIV; Human Immunodeficiency Virus type-1; HIVDR; HIV drug resistance; NA; not applicable; NNRTI; non-nucleoside reverse transcriptase inhibitor; NRTI; nucleoside rever
Keywords: ADP; adenosine diphosphate; ALT; alanine aminotransferase; ATP; adenine triphosphate; CoA; coenzyme A; FAD; flavin adenine dinucleotide; FADH2; reduced flavin adenine dinucleotide; GPT; glutamate pyruvate transaminase; HIV; human immunodeficiency virus; L
Keywords: NRTI; Lon; SIRT3; eIF2α; Mitochondrial stressAAA+, ATPases associated with diverse cellular activities; AZT, Zidovudine; CHOP, CCAAT-enhancer-binding protein homologous protein; d4T, Stavudine; eIF2α, eukaryotic translation initiation factor 2α; ER, endop
Validation of an LC-MS/MS assay to simultaneously monitor the intracellular active metabolites of tenofovir, emtricitabine, and lamivudine in dried blood spots
Keywords: TFV; tenofovir; FTC; emtricitabine; 3TC; lamivudine; NRTI; nucleos(t)ide reverse transcriptase inhibitor; TFVdp; tenofovir diphosphate; FTCtp; emtricitabine triphosphate; 3TCtp; lamivudine triphosphate; Dried blood spot; Validation; HIV; Adherence monitor
GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus
Keywords: ABC; abacavir; ABVD; adriamycin, bleomycin, vinblastine and dacarbazine; Ara-C; cytosine arabinoside; AZT; zidovudine; BCNU; carmustine; BEACOPP; bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone; CDC; Centers fo
Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations
Keywords: HIV-1; Antiretroviral therapy; Nucleoside reverse transcriptase inhibitor; NRTI; Resistance; Dolutegravir;
Optimization of tenofovir release from mucoadhesive vaginal tablets by polymer combination to prevent sexual transmission of HIV
Keywords: ACDP; anhydrous calcium hydrogen phosphate; AIDS; acquired immunodeficiency syndrome; AUC0âtâ; area under the curve between time 0 and complete erosion; CH; chitosan; Dp; mean pore sizes; ERS; Eudragit® RS; FE-SEM; field-emission scanning electron mi
HIV-1 integrase inhibitor resistance among treatment naïve patients in the West of Scotland
Keywords: PI; protease inhibitor; NRTI; nucleoside reverse transcriptase inhibitor; NNRTI; non-nucleoside reverse transcriptase inhibitor; HAART; highly active anti-retroviral therapy; TDR; transmitted drug resistance; IDU; injecting drug user; MSM; men who have se
Tenofovir alafenamide (TAF) does not deplete mitochondrial DNA in human T-cell lines at intracellular concentrations exceeding clinically relevant drug exposures
Keywords: Mitochondrial toxicity; mtDNA synthesis; T-cells; NRTI; TAF; Tenofovir alafenamide; d4T; stavudine; ddC; dideoxycytidine; ddI; dideoxyinosine; NRTI; nucleoside reverse transcriptase inhibitor; PBMC; peripheral blood mononuclear cell; TAF; tenofovir alafen
Ultradeep sequencing of B and non-B HIV-1 subtypes: Viral diversity and drug resistance mutations before and after one month of antiretroviral therapy in naive patients
Keywords: ARV; antiretroviral; DRM; drug resistance mutation; HAART; highly active anti-retroviral therapy; HIV; human immunodeficiency virus; NGS; next generation sequencing; NRTI; nucleos(t)idic reverse transcriptase inhibitor; NNRTI; non-nucleosidic reverse tran
High FGF21 levels are associated with altered bone homeostasis in HIV-1-infected patients
Keywords: AST; aspartate transaminase; ALT; alanine transaminase; BMD; bone mineral density; BMC; bone mineral content; CTX-1; C-telopeptide of type-I collagen; DXA; dual-energy X-ray Absorptiometry; ELISA; enzyme-linked immunosorbent assay; FGF21; fibroblast growt
Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance
Keywords: ART; antiretroviral therapy; TasP; Treatment-as-Prevention; NRTI; nucleoside reverse transcriptase (RT) inhibitor; NNRTI; non-nucleoside RT inhibitor; PI; protease inhibitor; INSTI; integrase strand transfer inhibitor; RAL; raltegravir; EVG; elvitegravir;
HIV and its relationship to insulin resistance and lipid abnormalities
Keywords: ABCA1; adenosine-triphosphate-binding cassette transporter A1; AIDS; acquired immunodeficiency syndrome; AMI; acute myocardial infarction; Apo-B; apolipoprotein B; cART; combined antiretroviral therapy; CRP; c-reactive protein; DM; diabetes mellitus; HDL-
Astrocyte elevated gene-1 (AEG-1) and the A(E)Ging HIV/AIDS-HAND
Keywords: Astrocytes; Aging; HIV-associated neurocognitive disorders; Neuroinflammation; ER/Nucleolar/Oxidative stress; Excitotoxicity; Aβ; amyloid beta; AEG-1; astrocyte elevated gene-1; AD; Alzheimer's disease; AIDS; acquired immune deficiency syndrome; ARE; a
Predicting CD4 count changes among patients on antiretroviral treatment: Application of data mining techniques
Keywords: CD4 count change; Antiretroviral treatment; Computational methods; Random Forest; Neural Network; J48, Decision tree; ABC; Abacavir; ddI; Didanosine; d4T; Stavudin; EFV; Efavirenz; FTC; Emotricitabine; LPV/r; Lopinavir/ritonavir; NFV; Nelfinavir; NNRTI; N
Evaluation of mHealth strategies to optimize adherence and efficacy of Option B+ prevention of mother-to-child HIV transmission: Rationale, design and methods of a 3-armed randomized controlled trial
Keywords: ANC; antenatal care; ART; antiretroviral therapy; CDC; Centers for Disease Control and Prevention; eMTCT; elimination of mother-to-child HIV transmission; FGD; focus group discussion; IDI; in-depth interviews; KEMRI; Kenya Medical Research Institute; mHea
Mitochondrial defects arise from nucleoside/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders
Keywords: NRTI; nucleoside/nucleotide reverse transcriptase inhibitor; HAND; HIV-associated neurocognitive disorders; cART; combination antiretroviral therapy; pol γ; polymerase γ; mtDNA; mitochondrial DNA; ddI; didanosine; AZT; zidovudine; FTC; emtricitabine; TD
Azidothymidine-triphosphate impairs mitochondrial dynamics by disrupting the quality control system
Keywords: ATP; adenosine triphosphate; AZT; 3ê-azido-3ê-deoxythymidine; AZT-DP; AZT diphosphate; AZT-MP; AZT monophosphate; AZT-TP; AZT-triphosphate; calcein-AM; calcein acetoxymethyl ester; cDNA; complementary DNA; DHE; dihydroethidium; DMEM; Dulbecco's Modifi
The trend of transmitted drug resistance in newly diagnosed antiretroviral-naive HIV/AIDS patients during 1999-2012 in South Korea
Keywords: Transmitted resistance; HIV-1 pol; NRTI; NNRTI; PI;
Blockade of the spinal BDNF-activated JNK pathway prevents the development of antiretroviral-induced neuropathic pain
Keywords: Antiretroviral; Neuropathic pain; JNK; BDNF; Caspase-3; ATF3; activating transcription factor 3; ddC; 2â²,3â²-dideoxycitidine; d4T; 2â²,3â²-didehydro-3â²-deoxythymidin; DRG; dorsal root ganglia; i.p.; intraperitoneal; i.t.; intrathecal; JNK; c-Jun N-
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae
Keywords: d4T; 3â²-deoxy-2â²,3â²-didehydrothymidine or stavudine; ddC; 2â²,3â²-dideoxycytidine or zalcitabine; Ed4T; 2â²,3â²-didehydro-3â²-deoxy-4â²-ethynylthymidine; EryR; resistant to erythromycin; exo; exonuclease; FLT; 3â²-fluoro-3â²-deoxythymidine;
NRTI-sparing regimens yield higher rates of drug resistance than NRTI-based regimens for HIV-1 treatment
Keywords: HIV-1; NRTI; Resistance
A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral therapy
Keywords: ART; antiretroviral therapy; WHO; World Health Organisation; PI; protease inhibitor; DBS; dried blood spot; ADR; antiretroviral drug resistance; NHLS; National Health Laboratory Service; RT; Reverse Transcriptase Coding Region of Pol Gene; NNRTI; non-nucl
Expression of ATP-binding cassette membrane transporters in a HIV-1 transgenic rat model
Keywords: ARVs; antiretroviral drugs; ABC; ATP-binding cassette; BBB; blood-brain barrier; Bcrp/BCRP; breast cancer resistance protein; CNS; central nervous system; GSH; glutathione; GSSG; glutathione disulfide gp120, HIV-1 glycoprotein-120; HIV; human immunodefi
Overexpression of mitochondrial antioxidant manganese superoxide dismutase (MnSOD) provides protection against AZT- or 3TC-induced endothelial dysfunction
Keywords: Endothelial dysfunction; NRTI; Atherosclerosis; Antioxidants;
A new antiviral: Chimeric 3TC-AZT phosphonate efficiently inhibits HIV-1 in human tissues ex vivo
Keywords: HIV-1; NRTI; Depot form;
Prognostic Indicators for Recurrent Thrombotic Events in HIV-infected Patients with Acute Coronary Syndromes: Use of Registry Data From 12 sites in Europe, South Africa and the United States
Keywords: ACS; Acute coronary syndromes; CABG; Coronary artery bypass grafting; CV; Cardiovascular; HAART; Highly active antiretroviral therapy; HIV; Human immunodeficiency virus; LVSD; Left ventricular systolic dysfunction; MI; Myocardial infarction; NRTI; Nucleos
Neutrophils in antiretroviral therapy-controlled HIV demonstrate hyperactivation associated with a specific IL-17/IL-22 environment
Keywords: Neutrophils; HIV; inflammation; IL-18; IL-17; IL-22; 7-AAD; 7-Amino-actinomycin D; APC; Allophycocyanin; ART; Antiretroviral therapy; FITC; Fluorescein isothiocyanate; HC; Healthy control subject; HIV(I); HIV-infected patients with inflammatory diseases;
Evaluation of the automatic editing tool RECall for HIV-1 pol and V3 loop sequences
Keywords: AA; amino acid; ART; antiretroviral therapy; env; envelope gene; EQA; external quality assessment; FPR; false positive rate; HIV-1; human immunodeficiency virus type 1; NNRTI; non-nucleoside reverse transcriptase inhibitor; NRTI; nucleoside reverse transc
5,6-Dihydro-5-aza-2â²-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors
Keywords: 5-AZC; 5-azacytidine; dFdC; 2â²,2â²-difluoro-2â²-deoxycytidine; dFdU; 2â²,2â²-difluoro-2â²-deoxyuridine; DMSO; dimethylsulfoxide; KP-1212; 5-aza-5,6,-dihydro-2â²-deoxycytidine; MOI; multiplicity of infection; NRTI; nucleoside reverse transcriptase
Comparative analysis of genetic toxicity of antiretroviral combinations in somatic cells of Drosophila melanogaster
Keywords: NRTI; nucleoside reverse transcriptase inhibitor; HAART; highly active antiviral therapy; AZT; 3â²-azido-3â²-deoxythymidine; ddI; 2â²,3â²-dideoxyinosine; 3TC; [â] 2â²-deoxy-3â²-thiacytidine; d4T; 3â²-deoxy-2â²,3â²-didehydrothymidine; SMART; som
Bifunctional inhibition of HIV-1 reverse transcriptase: A first step in designing a bifunctional triphosphate
Keywords: HIV-1; human immunodeficiency virus type 1; RT; reverse transcriptase; NRTIs; nucleoside RT inhibitors; NNRTIs; nonnucleoside RT inhibitors; dNTP; deoxynucleoside triphosphate; dNMP; 3â²-deoxynucleoside monophosphate; PPi; pyrophosphate; AZT; β-d-(+)-3â
Lipid profile changes by high activity anti-retroviral therapy
Keywords: Lipid profile; Dyslipidaemia; Lipodystrophy; HIV; HAART; PI; NRTI; NNRTI
Growth and Body Composition of Uninfected Children Exposed to Human Immunodeficiency Virus: Comparison with a Contemporary Cohort and United States National Standards
Keywords: ARV; Antiretroviral; BMI; Body mass index; CDC; Centers for Disease Control; HCZ; Head circumference-for-age z-score; LAZ; Length-for-age z-score; MAC; Mid-upper arm circumference; NHANES; National Health and Nutrition Examination Survey; NRTI; Nucleoside
Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistance
Keywords: Subtype C; Connection domain; NRTI; NNRTI; Drug resistance
Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides
Keywords: CGRP; calcitonin gene related peptide; CaV2.2; N-type voltage-gated Ca2+ channel; CBD; Ca2+ channel binding domain; CRMP2; collapsin response mediator protein 2; CPP; cell penetrating peptide; CNS; central nervous system; Ï-CTX; omega-conotoxin; DIV; day
Datos de rilpivirina en pacientes naïve. Lecciones de los estudios ECHO, THRIVE y STaR
Keywords: Tratamiento antirretroviral de inicio; Naïve; Rilpivirina; Efavirenz; Inhibidores de la transcriptasa inversa no; análogos de nucleósidos; Eficacia; Seguridad; ResistenciasRilpivirine; Efavirenz; NNRTI; NRTI; Efficacy; Safety; Virological failure; Resista
Original Full Length ArticleExposure to antiretroviral agents during pregnancy does not alter bone status in infants
Keywords: HIV; human immunodeficiency virus; ARV; antiretroviral treatment; PMTCT; prevention of HIV mother-to-child transmission; SOS; speed of sound; BAP; bone alkaline phosphatase; CTX; C-terminal telopeptide of type I collagen; NRTI; nucleoside reverse transcri
Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes
Keywords: ART; antiretroviral therapy; DBS; dried blood spot; LOD; limit of detection; NNRTI; non-nucleoside reverse transcriptase inhibitor; NRTI; nucleoside reverse transcriptase inhibitor; Nt; nucleotide; PI; protease inhibitor; PMTCT; prevention-of-mother-to-ch
HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures
Keywords: HIV-1; human immunodeficiency virus type 1; MTCT; mother-to-child transmission; ARV; antiretroviral; PPPW; Program for the Protection of Pregnant Women; HAART; highly active antiretroviral therapy; NRTI; nucleoside reverse-transcriptase inhibitors; NNRTI;
Structure-activity relationship study of pyrimido[1,2-c][1,3]benzothiazin-6-imine derivatives for potent anti-HIV agents
Keywords: CCR5; CC chemokine receptor type 5; CXCR4; CXC chemokine receptor type 4; MAGI; Multinuclear activation of a galactosidase indicator; NNRTI; Non-nucleoside reverse transcriptase inhibitors; NRTI; Nucleoside reverse transcriptase inhibitors; Anti-HIV agent
High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in Cuba
Keywords: ART; antiretroviral therapy; CI; confidence interval; NRTI; nucleoside reverse transcriptase inhibitor; NNRTI; non-nucleoside RTI; PI; protease inhibitor; FCR; full-class resistance; CRF; circulating recombinant form; HIV; human immunodeficiency virus; MD
In vitro supplementation with deoxynucleoside monophosphates rescues mitochondrial DNA depletion
Keywords: COX; cytochrome c oxidase; COX II; cytochrome c oxidase subunit II; DGUOK; deoxyguanosine kinase; dNMP; deoxy-nucleoside monophosphate; dNDP; deoxy-nucleoside diphosphate; dNTP; deoxy-nucleoside triphosphate; HIV; human immunodeficiency virus; HRP; horser
Profile of stress and toxicity gene expression in human hepatic cells treated with Efavirenz
Keywords: EFV; Efavirenz; HAART; highly active antiretroviral therapy; NRTI; nucleoside reverse transcriptase inhibitor; NNRTI; non-nucleoside reverse transcriptase inhibitor; ROS; reactive oxygen species; ÎΨm; mitochondrial transmembrane potential; DNA; polymera